All Online

1 - 12 of 15 results

Refine

Active filters

Coronavirus Disease (COVID-19)
Tile overview image
1 CME CREDIT

bottle spilling white pills on flat surface
1 CME CREDIT

New Drugs for the PCP: What You Need to Know

1.00 CME/MOC
1.00 AANP | 1.00 Pharmacology

Keeping up with the many new drugs approved for use each year is a constant challenge. However only a small number of new drugs each year are novel, work by a new mechanism, and are relevant for primary care practice. This talk provides a balanced evaluation of these important novel drugs, and will address efficacy, side effects, cost, and the impact on primary care practice. In addition, we will discuss at length the efficacy and safety of the COVID vaccines available in the U.S. through Emergency Use Authorization.


pediatric physician flexing with young patient and mother in the back
1 CME CREDIT

Hot Topics in Pediatric Infectious Diseases

1.00 CME/MOC
1.00 AANP | 0.50 Pharmacology

Dr. Deborah Lehman will review pediatric infectious disease hot topics for the general practitioner. Learners will hear updates on the COVID-19 pandemic, measles and the state of vaccine hesitancy.


physician performing medical exam to elder patient sitting with mask on
1 CME CREDIT

This pandemic required communication among specialists and primary care. In this COVID-19 panel, faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.


man and woman elbow bumping
0.5 CME CREDIT

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss trends in substance use throughout the pandemic and common clinical questions about thrombosis and antithrombotic therapy in patients with SARS-CoV-2 infection.


Tile overview image
1 CME CREDIT

COVID-19 Cases in Primary Care

1.00 CME/MOC
1.00 AANP | 0.75 Pharmacology


Coronavirus New Strain Wide Dark Background
1 CME CREDIT

COVID-19 Panel Discussion: December 2021

1.00 CME/MOC
1.00 AANP | 0.50 Pharmacology

This pandemic required communication among specialists and primary care. In this COVID-19 panel, faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.


Bunch of red pills
0.5 CME CREDIT

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! There’s new information about vaccines daily but it can be challenging to keep up. In additions there is new data on emerging treatment options. Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss the most recent vaccine efficacy data, the recommendations for boosters, and the new efficacy and safety data for molnupiravir.


Coffee with Chopra: Episode 2
0.5 CME CREDIT

In this episode of Coffee with Chopra, Dr. Sanjiv Chopra will interview family practitioner, Dr. Frank Domino. They will discuss the latest data on vitamin D supplementation, the importance of exercise and how to motivate patients to exercise, new and emerging diets and how these diets can impact patients with certain health issues including diabetes and NAFLD, and new data around proton pump inhibitor (PPI) use and COVID-19. As Hippocrates said, “Let thy food be thy medicine.”


Coronavirus New Strain Wide Dark Background
1 CME CREDIT

COVID-19 Update: Panel Discussion (January 2022)

1.00 CME/MOC
1.00 AANP | 0.33 Pharmacology


image of children getting vaccinated with a mask on
0.5 CME CREDIT

With ever-changing information on the 2019 novel coronavirus (COVID-19), it is hard to keep the facts straight! There’s new information about vaccines daily but it can be challenging to keep up. Join Drs. Charles Vega and Ty Gluckman as they team up live to discuss vaccines for children 5-11 years old, and vaccine-associated Myocarditis.


Frankly Speaking CME 265
0.25 CME CREDIT

Fluvoxamine as a Treatment for COVID-19 - Frankly Speaking EP 265

Guest: Alan M. Ehrlich, MD, FAAFPMusic Credit: Richard Onorato

0.25 CME

Most cases of COVID-19 will resolve without interventions, but some patients are at high risk for complications. Several treatment options for high-risk patients are now available to help prevent the need for hospitalization. Join us to review a recent large, randomized trial evaluating fluvoxamine as a treatment for high-risk patients who were diagnosed with COVID-19.